Homologous Pfizer-BioNTech Booster Safe for Adolescents
THURSDAY, March 3, 2022 (HealthDay News) — For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receipt of the second vaccine dose, and they are generally mild to moder…
Learn MoreSackler Family and Purdue Pharma Reach Deal With U.S. States Over Opioid Crisis
THURSDAY, March 3, 2022 (HealthDay News) — A deal has been reached between members of the Sackler family and their company, Purdue Pharma, to settle thousands of lawsuits over their role in the U.S. opioid epidemic.In return for an end to all current…
Learn MoreWhite House Unveils New COVID-19 Response Strategy
THURSDAY, March 3, 2022 (HealthDay News) — Accelerated research into new vaccines that could be ready within 100 days of the emergence of a new variant is one of the key features of a new COVID-19 response strategy released by the White House on Wedn…
Learn MoreSuicide Mortality Decreased From 2018 to 2020 After Rising Since 2000
THURSDAY, March 3, 2022 (HealthDay News) — Suicide mortality increased from 2000 to 2018, then decreased from 2018 to 2020, according to a February data brief published by the U.S. Centers for Disease Control and Prevention National Center for Healt…
Learn MoreE-Cigarette Use Linked to Increased Odds of Prediabetes
THURSDAY, March 3, 2022 (HealthDay News) — Use of electronic cigarettes is associated with an increased likelihood of prediabetes, according to a study published online March 3 in the American Journal of Preventive Medicine.Zhenyu Zhang, Ph.D., from …
Learn MoreAAN: Years of Ice Hockey Play Increase Risk for Chronic Traumatic Encephalopathy
THURSDAY, March 3, 2022 (HealthDay News) — There is a dose-response relationship between years of ice hockey play and chronic traumatic encephalopathy (CTE) risk and severity, according to a study scheduled for presentation at the upcoming annual mee…
Learn MoreAAN Issues Review of Evidence for Aducanumab in Alzheimer Disease
THURSDAY, March 3, 2022 (HealthDay News) — The evidence for use of aducanumab in individuals with early symptomatic Alzheimer disease is presented in a report from the American Academy of Neurology Guidelines subcommittee published online Feb. 23 in …
Learn MoreEarly Posttraumatic Seizures Tied to Worse Traumatic Brain Injury Outcomes
THURSDAY, March 3, 2022 (HealthDay News) — Early posttraumatic seizures (EPS) after moderate-to-severe traumatic brain injury (TBI) are associated with poor outcomes, according to a study published online Feb. 21 in JAMA Neurology.Joshua Laing, M.B.B…
Learn MoreOverdose Deaths From Non-BZD Hypnotics/Sedatives Up in the U.S.
THURSDAY, March 3, 2022 (HealthDay News) — Overdose deaths due to nonbenzodiazepine hypnotics and gabapentinoids increased significantly during the last two decades, according to a study published online Jan. 24 in The Lancet Regional Health-Americas…
Learn MoreMany Older Adults Still Have Not Received Care Delayed by COVID-19
THURSDAY, March 3, 2022 (HealthDay News) — The pandemic disrupted health care for around 30 percent of older adults, according to the results of the latest University of Michigan National Poll on Healthy Aging.Jeffrey Kullgren, M.D., from the Univer…
Learn More